November 10, 2014
TraceLink Inc., the leader in protecting patient safety and enabling health for global Life Sciences, today announced that it will enable any business within the pharmaceutical supply chain to achieve January 1, 2015 Drug Supply Chain Security Act (DSCSA) compliance within a one-week implementation timeframe. In anticipation of the January deadline, a range of companies have been developing compliance processes on their own or with a 3PL partner, but many do not yet have a viable solution, leaving them vulnerable to DSCSA regulations that take effect in less than eight weeks.
To ensure that no company is out of compliance on January 1, 2015 or is unable to meet trading partner requirements on that date, TraceLink is offering a new one-week DSCSA compliance solution that includes its fully featured Product Track transaction history management system and complete connectivity to the Life Sciences Cloud and its network of thousands of suppliers and trading partners – all with streamlined setup and configuration services to reduce set-up costs and guarantee deployment within 5 business days.
“For months, TraceLink has been working with the world’s leading pharmaceutical manufacturers, distributors, repackagers, and dispensers to ensure they are ready to meet the DSCSA deadline on January 1. But with less than two months to go, we’re still seeing a lot of other companies scrambling to get an operational plan in place,” said Shabbir Dahod, president and CEO of TraceLink. “Companies that have been pursuing a home-grown solution using ASNs and paper, or trusting their 3PL to manage the process for them, are starting to realize that they will not be ready in time. TraceLink’s proven and cost-effective DSCSA solution used by the majority of top-20 pharmaceutical companies is now within their reach. After a quick one-week implementation process, they’ll have a complete compliance solution in place, including the ability to send and receive all the required DSCSA documents to and from any company in their ecosystem of trading partners.”
DSCSA Compliance within a Week
TraceLink delivers the only mature, field-tested cloud platform that minimizes the cost, risk and time associated with meeting the complex set of DSCSA drug tracing, verification and archival regulations that take effect on January 1, 2015. In most cases, pharmaceutical companies find that 90% of their suppliers and trading partners are already on the TraceLink Life Science Cloud, which immediately enables them to begin sharing DSCSA documentation throughout their entire supply chain. To ensure DSCSA compliance within a week, TraceLink’s DSCSA experts will:
To understand how TraceLink can help you prepare for January 1 DSCSA and implement its proven and cost-effective solution used by the majority of top-20 pharmaceutical companies in just 5 days, visit DSCSA in a Week.
TraceLink protects patients, enables health and ensures compliance for companies across the global Life Sciences supply network, including fourteen of the top-20 global pharmaceutical companies. Leading businesses trust the TraceLink Life Sciences Cloud, our Amazon AWS-based cloud application platform, to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. Winner of numerous industry awards including the Amazon AWS Global Start-Up Challenge Grand Prize and the Edison Award for Innovation in Health Management, the TraceLink Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com.
TraceLink is funded by FirstMark Capital. FirstMark Capital is an early stage venture capital firm based in New York City. FirstMark’s mission is to partner with exceptional entrepreneurs who are changing the world by solving meaningful problems. FirstMark has built a deeply engaged community among the extraordinary teams in the FirstMark network to spread ideas and opportunities. FirstMark is privileged to work alongside the founders of remarkable businesses like Pinterest, Lumosity, Aereo, TapAd, Shopify, Riot Games, and dozens more. Visit FirstMark in New York City or online at firstmarkcap.com and @FirstMarkCap.